| Sodium Valproate – MO opportunities |
Prescribing Data Report |
April 2026 |
| Antidepressants – MO opportunities |
Prescribing Data Report |
March 2026 |
| Formulary assessment – levodopa inhalation powder (Inbrija) |
Formulary assessment tools |
March 2026 |
| Opioids – MO opportunities |
Prescribing Data Report |
April 2026 |
| Budget impact of prescribing haloperidol 500 microgram tablets |
Prescribing bulletin |
September 2025 |
| Formulary assessment – Pregabalin prolonged-release tablets |
Formulary assessment tools |
June 2025 |
| NHS Medicines Optimisation Opportunities Dashboard |
Prescribing Data Report |
May 2025 |
| Drugs for Dementia |
Prescribing Data Report |
February 2026 |
| Safer Medication Use – Propranolol in the treatment of anxiety |
Safer Medication Use |
October 2024 |
| Disease-modifying therapies for Alzheimer’s disease |
Evaluation report |
September 2024 |
